Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience.
Nalinie Joharatnam-HoganWilliam WilsonKai Keen ShiuGiuseppe Kito FusaiBrian DavidsonDaniel HochhauserJohn BridgewaterKhurum KhanPublished in: Cancers (2020)
Multimodal therapy for metastatic bowel cancer is associated with significant survival benefit. Resection/radical RT of the primary and resection of metastatic disease should be considered to improve survival outcomes following multidisciplinary team (MDT) discussion and individual assessment of fitness.
Keyphrases
- metastatic colorectal cancer
- squamous cell carcinoma
- small cell lung cancer
- pain management
- papillary thyroid
- healthcare
- physical activity
- quality improvement
- body composition
- palliative care
- type diabetes
- squamous cell
- lymph node metastasis
- metabolic syndrome
- combination therapy
- insulin resistance
- replacement therapy